Neuronetics (STIM) Revenue (2017 - 2026)

Neuronetics (STIM) has 10 years of Revenue data on file, last reported at $34.5 million in Q1 2026.

• Revenue for Q1 2026 came in at $34.5 million, up 7.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $151.6 million (up 69.52% YoY), and the FY2025 annual result was $149.2 million, up 99.17% from the prior year.
• Revenue fell to $34.5 million in Q1 2026 per STIM's latest filing, from $41.8 million in the prior quarter.
• Over five years, Revenue peaked at $41.8 million in Q4 2025 and troughed at $14.2 million in Q1 2022.
• A 5-year average of $23.2 million and a median of $18.2 million in 2022 frame the typical range for Revenue.
• The sharpest annual moves came in 2024 and 2025: Revenue retreated 6.59% in 2024, then jumped 131.66% in 2025.
• A 5-year view of Revenue shows it stood at $18.2 million in 2022, then grew by 11.63% to $20.3 million in 2023, then rose by 10.73% to $22.5 million in 2024, then surged by 85.73% to $41.8 million in 2025, then slipped by 17.53% to $34.5 million in 2026.
• Business Quant data shows STIM's Revenue at $34.5 million in Q1 2026, $41.8 million in Q4 2025, and $37.3 million in Q3 2025.